Anavex Life Sciences
AVXL
#7563
Rank
ยฃ0.29 B
Marketcap
ยฃ3.30
Share price
-1.12%
Change (1 day)
-44.55%
Change (1 year)

Anavex Life Sciences (AVXL) - Cash on Hand

Cash on Hand as of June 2025 : ยฃ75.93 Million

According to Anavex Life Sciences 's latest financial reports the company has ยฃ75.93 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Anavex Life Sciences - Cash on Hand chart (from 2005 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-09-30ยฃ98.82 M-20.19%
2023-09-30ยฃ0.12 B-7.63%
2022-09-30ยฃ0.13 B18.71%
2021-09-30ยฃ0.11 B398.72%
2020-09-30ยฃ22.64 M25.43%
2019-09-30ยฃ18.05 M2.65%
2018-09-30ยฃ17.58 M-14.14%
2017-09-30ยฃ20.48 M189%
2016-09-30ยฃ7.08 M-29.9%
2015-09-30ยฃ10.11 M125.73%
2014-09-30ยฃ4.47 M2001.04%
2013-09-30ยฃ0.21 M2925.43%
2012-09-30ยฃ0 M-91.83%
2011-09-30ยฃ0.08 M-48.78%
2010-09-30ยฃ0.16 M-23.7%
2009-09-30ยฃ0.22 M6045.45%
2008-09-30ยฃ0 M29269.87%
2007-09-30ยฃ0 M-99.81%
2006-09-30ยฃ0 M1082.01%
2005-09-30ยฃ0 M-96.45%
2004-09-30ยฃ0.01 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Ligand Pharmaceuticals
LGND
ยฃ0.50 B 569.15%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
ยฃ0.15 B 110.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
ยฃ0.31 B 316.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
ยฃ1.89 M-97.51%๐Ÿ‡บ๐Ÿ‡ธ USA